A Transgenic Model of Visceral Obesity and the Metabolic Syndrome
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
The adverse metabolic consequences of obesity are best predicted by the quantity of visceral fat. Excess glucocorticoids produce visceral obesity and diabetes, but circulating glucocorticoid levels are normal in typical obesity. Glucocorticoids can be produced locally from inactive 11-keto forms through the enzyme 11β hydroxysteroid dehydrogenase type 1 (11β HSD-1). We created transgenic mice overexpressing 11β HSD-1 selectively in adipose tissue to an extent similar to that found in adipose tissue from obese humans. These mice had increased adipose levels of corticosterone and developed visceral obesity that was exaggerated by a high-fat diet. The mice also exhibited pronounced insulin-resistant diabetes, hyperlipidemia, and, surprisingly, hyperphagia despite hyperleptinemia. Increased adipocyte 11β HSD-1 activity may be a common molecular etiology for visceral obesity and the metabolic syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“other health outcomes associated with better quality of life improved, including sleep apnoea136 and mobility137.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [137]
Citations
Cites
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Kopelman, P. G. (2000) · Nature · doi:10.1038/35007508 · Cited by 4,795
The hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes
Scherer, P. E., Williams, S., Fogliano, M., Baldini, G., & Lodish, H. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26746 · Cited by 3,237
Role of leptin in the neuroendocrine response to fasting
Ahima, R. S., Prabakaran, D., Mantzoros, C., Qu, D., Lowell, B., Maratos-Flier, E., & Flier, J. S. (1996) · Nature · doi:10.1038/382250a0 · Cited by 3,117
Self-citationSubcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961
Ahima, R. S., & Flier, J. S. (2000) · Annual Review of Physiology · doi:10.1146/annurev.physiol.62.1.413 · Cited by 1,428
Self-citationThe Degree of Masculine Differentiation of Obesities
VAGUE, J. (1956) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/4.1.20 · Cited by 1,410
Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver
Abel, E. D., Peroni, O., Kim, J. K., Kim, Y.-B., Boss, O., Hadro, E., Minnemann, T., Shulman, G. I., & Kahn, B. B. (2001) · Nature · doi:10.1038/35055575 · Cited by 1,253
Frühbeck, G., Gómez-Ambrosi, J., Muruzábal, F. J., & Burrell, M. A. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.6.e827 · Cited by 974
Research works printed but not linked: 5
- 10.1210/jcem.86.3.7453 · doi:10.1210/jcem.86.3.7453 · Paper page
- 10.1101/gad.7.7b.1318 · doi:10.1101/gad.7.7b.1318 · Paper page
- Supplementary data are available on Science Online at www.sciencemag.org/cgi/content/full/294/5549/2166/DC1.
- Strack A. M., Bradbury M. J., Dallman M. F., Am. J. Physiol. 268, R183 (1995).
- 10.1210/jcem.83.5.4951 · doi:10.1210/jcem.83.5.4951 · Paper page
Cited by
Items 901–1,000 of 1,003
Shafqat, N., Elleby, B., Svensson, S., Shafqat, J., Jörnvall, H., Abrahmsén, L., & Oppermann, U. C. T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210135200 · Cited by 29
Page, S. T., Krauss, R. M., Gross, C., Ishida, B. Y., Heinecke, J. W., Tang, C., Amory, J. K., Schaefer, P. M., Cox, C. J., Kane, J. P., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2813 · Cited by 28
“Antagonism of cortisol actions in peripheral tissues would be expected to reverse high triglyceride levels (4), central obesity (31, 32), and insulin resistance (33), all of which FIG.”
BackgroundMan, T. Y., Michailidou, Z., Gökçel, A., Ramage, L. E., Chapman, K. E., Kenyon, C. J., Seckl, J. R., & Morton, N. M. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00531.2010 · Cited by 28
“Transgenic overexpression of 11 -HSD1 in mouse adipose tissue causes insulin-resistant diabetes, dyslipidemia, and hypertension (23, 24).”
BackgroundSelf-citationUwazie, J. N., Yakubu, M. T., Ashafa, A. O. T., & Ajiboye, T. O. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112997 · Cited by 28
Barrientos‐Alvarado, C., Racotta, R., & Quevedo, L. (2010) · Nutrition Research · doi:10.1016/j.nutres.2010.10.008 · Cited by 28
“The abdominal region was immediately dissected, and the intraabdominal fat depots [25] and liver were excised and weighed.”
Altered Peripheral Sensitivity to Glucocorticoids in Primary Open-Angle Glaucoma
Stokes, J., Walker, B. R., Campbell, J. C., Seckl, J. R., O'Brien, C. J., & Andrew, R. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-1318 · Cited by 28
Self-citationMalavasi, E. L. V., Kelly, V., Nath, N., Gambineri, A., Dakin, R. S., Pagotto, U., Pasquali, R., Walker, B. R., & Chapman, K. E. (2009) · Endocrinology · doi:10.1210/en.2009-0663 · Cited by 28
“These mice develop all the major features of metabolic syndrome including central obesity, insulin resistance, dyslipidaemia and hypertension (5, 6).”
Dube, S., Slama, M. Q., Basu, A., Rizza, R. A., & Basu, R. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2673 · Cited by 28
Optimization of novel di-substituted cyclohexylbenzamide derivatives as potent 11β-HSD1 inhibitors
McMinn, D. L., Rew, Y., Sudom, A. M., Caille, S., DeGraffenreid, M. R., He, X., Hungate, R. W., Jiang, B., Jaén, J. C., Julian, L. D., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.01.026 · Cited by 28
Portal and peripheral cortisol levels in obese humans
Aldhahi, W., Goldfine, A. B., & Mun, E. (2004) · Diabetologia · doi:10.1007/s00125-004-1389-4 · Cited by 28
“Selective overexpression of 11β HSD-1 in adipose tissues of rodents causes the metabolic syndrome phenotype, and mice with increased expression of 11β HSD1 have higher portal cortisol levels and an increased risk of developing visceral obesity and diabetes [10].”
BackgroundInfluentialLessons in obesity from transgenic animals
Arch, J. R. S. (2002) · Journal of Endocrinological Investigation · doi:10.1007/bf03344050 · Cited by 28
Bat breath reveals metabolic substrate use in free-ranging vampires
Voigt, C. C., Grasse, P., Rex, K., Hetz, S. K., & Speakman, J. R. (2007) · Journal of Comparative Physiology B · doi:10.1007/s00360-007-0194-z · Cited by 28
Sakamuri, S. S. V. P., Kumar, S. S. J., Kumar, P. U., Qadri, S. S. Y. H., & Vajreswari, A. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-111 · Cited by 27
“Mice over expressing 11b-HSD1 in adipose tissue are modestly obese and develop all other features of metabolic syndrome including insulin resistance [2].”
BackgroundChung, G. K.-K., Chung, R. Y., Chan, D. C.-C., Lai, F. T. T., Wong, H., Lau, M. K.-W., Wong, S. Y. S., & Yeoh, E. (2018) · Journal of Public Health · doi:10.1093/pubmed/fdy161 · Cited by 27
Deng, X., Shen, Y., Yang, J., He, J., Zhao, Y., Peng, L., Leng, Y., & Zhao, Q. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.05.010 · Cited by 27
Ajiboye, T. O., Iliasu, G. A., Adeleye, A. O., Ojewuyi, O. B., Kolawole, F. L., Bello, S. A., & Mohammed, A. O. (2015) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.7150 · Cited by 27
Haridas, V., Xu, Z., Kitchen, D. B., Jiang, A., Michels, P. C., & Gutterman, J. U. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028037 · Cited by 27
“Adipose redistribution, one of the undesirable results of GC treatment is a result of GR-induced transactivation of genes involved in adipocyte differentiation [47].”
BackgroundNammi, S., Dembélé, K., & Nyomba, B. L. G. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00255.2006 · Cited by 27
“Leptin-resistant db/db mice, which are hypercortisolemic, also have elevated hepatic 11 HSD1 in association with increased phosphoenolpyruvate carboxykinase mRNA expression and high blood glucose (34), whereas transgenic mice overexpressing 11 -HSD1 selectively in adipocytes have increased adipose levels of corticoste…”
BackgroundHypothalamus transcriptome profile suggests an anorexia-cachexia syndrome in the anx/anx mouse model
Mercader, J. M., Lozano, J. J., Sumoy, L., Dierssen, M., Visa, J., Gratacòs, M., & Estivill, X. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.90255.2008 · Cited by 27
“Figure legends *these genes have a role in body weight and eating behavior regulation: Hsd11b1, Orexigenic (50, 55); Ncor1, PPARG signaling (63); Plcb1, PPARG signaling (63); Ppargc1a, PPARG signaling (63) Table 3.”
BackgroundMichailidou, Z., Coll, A. P., Kenyon, C. J., Morton, N. M., O’Rahilly, S., Seckl, J. R., & Chapman, K. E. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0090 · Cited by 27
“Increased glucocorticoid action specifically in adipose (Masuzaki et al. 2001) or liver (Paterson et al.”
BackgroundSelf-citationCrowley, R. K., Hughes, B., Gray, J., McCarthy, T., Hughes, S., Shackleton, C. H. L., Crabtree, N., Nightingale, P., Stewart, P. M., & Tomlinson, J. W. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0256 · Cited by 26
Liu, J., Wang, L., Zhang, A., Di, W., Zhang, X., Wu, L., Yu, J., Zha, J., Lv, S., Cheng, P., et al. (2011) · Endocrine Journal · doi:10.1507/endocrj.k10e-318 · Cited by 26
“Future more, several transgenic mice models have supported that adipose tissue 11βHSD1 plays a key role in the pathogenesis of visceral obesity and the metabolic syndrome [5, 15, 22, 24].”
BackgroundAndo, Y., Saito, S., Miura, H., Osaki, N., & Katsuragi, Y. (2017) · Nutrition Research · doi:10.1016/j.nutres.2017.10.012 · Cited by 26
“Accumulation of visceral fat area is more closely associated with metabolic risk factors than BMI or subcutaneous fat [55, 56].”
BackgroundKoška, J., de Courten, B. V., Wake, D. J., Nair, S., Walker, B. R., Bunt, J. C., Permana, P. A., Lindsay, R. S., & Tataranni, P. A. (2006) · Obesity · doi:10.1038/oby.2006.175 · Cited by 26
“Unlike animal models (13,14), intra-adipose levels of cortisol in cross-sectional human studies are unrelated to 11 HSD1 activity or mRNA levels (20,23), and a similar result was observed in cross-sectional analyses of our subjects at baseline.”
North, K. E., Williams, J. T., Welty, T. K., Best, L. G., Lee, E. T., Fabsitz, R. R., Howard, B. V., & MacCluer, J. W. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802261 · Cited by 26
Kuhn, E., Bourgeois, C., Keo, V., Viengchareun, S., Muscat, A., Méduri, G., Menuet, D. L., Fève, B., & Lombès, M. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00323.2013 · Cited by 26
17β-Estradiol inhibits 11β-hydroxysteroid dehydrogenase type 1 activity in rodent adipocytes
Tagawa, N., Yuda, R., Kubota, S., Wakabayashi, M., Yamaguchi, Y., Kiyonaga, D., Mori, N., Minamitani, E., Masuzaki, H., & Kobayashi, Y. (2009) · Journal of Endocrinology · doi:10.1677/joe-09-0021 · Cited by 26
“The importance of local activation of glucocorticoids in adipose tissue has been demonstrated in transgenic mice overexpressing 11b-HSD1 under the control of the adiposespecific aP2 promoter/enhancer (Masuzaki et al. 2001).”
BackgroundInfluentialSelf-citationEsteves, C. L., Kelly, V., Bégay, V., Man, T. Y., Morton, N. M., Leutz, A., Seckl, J. R., & Chapman, K. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037953 · Cited by 26
“Transgenic overexpression of 11b-HSD1 in adipose tissue recapitulates the metabolic syndrome in mice, with visceral obesity, dyslipidemia, insulin resistance/diabetes and hypertension [2,5].”
BackgroundSelf-citationPickering, R. T., Lee, M., Karastergiou, K., Gower, A. C., & Fried, S. K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167337 · Cited by 26
Tagawa, N., Minamitani, E., Yamaguchi, Y., & Kobayashi, Y. (2011) · Steroids · doi:10.1016/j.steroids.2011.09.005 · Cited by 26
“11b-HSD1 has been proven to be a potential therapeutic target for the treatment of central obesity and metabolic syndrome in experimental animals [1,51] and humans [2–4].”
Usukura, M., Zhu, A., Yoneda, T., Karashima, S., Yagi, K., Yamagishi, M., & Takeda, Y. (2009) · Steroids · doi:10.1016/j.steroids.2009.07.006 · Cited by 26
Nakayama, S., Nishiyama, M., Iwasaki, Y., Shinahara, M., Okada, Y., Tsuda, M., Okazaki, M., Tsugita, M., Taguchi, T., Makino, S., et al. (2011) · Endocrine Journal · doi:10.1507/endocrj.k10e-370 · Cited by 26
“Local glucocorticoid excess could also occur in the abdominal adipose tissue, when glucocorticoid-activating enzyme (11β-hydroxysteroid dehydrogenase type 1) is overexpressed [8, 9].”
BackgroundJain, S., Tillinger, A., Mopidevi, B., Pandey, V. G., Chauhan, C. K., Fiering, S., Warming, S., & Kumar, A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.167585 · Cited by 26
Makimura, H., Mizuno, T. M., Beasley, J., Silverstein, J. H., & Mobbs, C. V. (2003) · BMC Physiology · doi:10.1186/1472-6793-3-4 · Cited by 26
Neuroendocrinology of insulin resistance: metabolic and endocrine aspects of adiposity
van Dijk, G., de Vries, K., Benthem, L., Nyakas, C. J., Buwalda, B., & Scheurink, A. J. W. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.090 · Cited by 26
“, 2000), adrenal (Masuzaki et al., 2001) and growth hormone (Nam and Lobie, 2000), and gonadal (Chehab, 2000) axes.”
Miguet, L., Zhang, Z., Barbier, M., & Grigorov, M. (2006) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-006-9037-3 · Cited by 26
Splanchnic Cortisol Production in Dogs Occurs Primarily in the Liver
Basu, R., Edgerton, D. S., Singh, R., Cherrington, A. D., & Rizza, R. A. (2006) · Diabetes · doi:10.2337/db06-0601 · Cited by 26
“Visceral cortisol uptake was calculated as: Visceral CU (PoVTcort PoV PF) Visceral ER D4cort (6) Visceral and liver cortisol production were calculated: Liver CP NLiver CB Liver CU (7) Visceral CP NVisceral CB Visceral CU (8) For the sake of clarity of presentation, cortisol production is expressed as a positive numbe…”
BackgroundInfluentialVicker, N., Su, X., Lawrence, H. R., Cruttenden, A., Purohit, A., Reed, M. J., & Potter, B. V. L. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.03.107 · Cited by 26
Rogers, S. L., Hughes, B. A., Jones, C. A., Freedman, L., Smart, K., Taylor, N., Stewart, P. M., Shackleton, C. H. L., Krone, N. P., Blissett, J., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3254 · Cited by 25
Inhibition of 11β-HSD1 by LG13 improves glucose metabolism in type 2 diabetic mice
Zhao, L., Pan, Y., Peng, K., Wang, Z., Li, J., Li, D., Tong, C., Wang, Y., & Liang, G. (2015) · Journal of Molecular Endocrinology · doi:10.1530/jme-14-0268 · Cited by 25
Targeting osteoblastic 11β-HSD1 to combat high-fat diet-induced bone loss and obesity
Zhong, C., Li, N., Wang, S., Li, D., Yang, Z., Du, L., Huang, G., Li, H., Yeung, W. S., He, S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52965-4 · Cited by 26
“…activation in bones of mice on CD1 background fed with 18-week HFD 17 , challenge the preconceived notions considering liver and adipose tissues as the primary organs with elevated 11 β -HSD1 and excessive GC action that majorly contribute to the adverse metabolic consequences of HFD 16,30 – 32 .”
Dhanesha, N., Joharapurkar, A. A., Shah, G. B., Kshirsagar, S. G., Dhote, V. V., Sharma, A. P., & Jain, M. R. (2011) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05640.x · Cited by 25
Benetti, C. D. S., Silveira, P. P., Portella, A. K., Diehl, L. A., Nunes, E., de Oliveira, V. S., Dalmaz, C., & Goldani, M. Z. (2007) · Pediatric Research · doi:10.1203/pdr.0b013e31813cbe8b · Cited by 25
Sakamuri, S. S. V. P., Anamthathmakula, P., Giridharan, N. V., & Vajreswari, A. (2011) · Nutrition Journal · doi:10.1186/1475-2891-10-70 · Cited by 25
“Transgenic mice overexpressing 11b-HSD1 in adipose tissue developed visceral obesity [3], where as 11b-HSD1 knock-out mice displayed resistance to diet-induced obesity [4].”
BackgroundInoue, E., Ichiki, T., Takeda, K., Matsuura, H., Hashimoto, T., Ikeda, J., Kamiharaguchi, A., & Sunagawa, K. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0014 · Cited by 25
“Accumulation of visceral fat rather than subcutaneous fat is believed to cause insulin resistance (Wajchenberg 2000, Masuzaki et al. 2001).”
BackgroundFunctional Hypercortisolism, Visceral Obesity, And Metabolic Syndrome
Min, L. (2016) · Endocrine Practice · doi:10.4158/ep161197.co · Cited by 25
“In animal studies, increased local conversion of inactive cortisone to active cortisol by type 1 11β-hydroxysteroid dehydrogenase in adipose tissue was identified as one of the major factors contributing to visceral obesity (11).”
Li, J., Kennedy, L. J., Wang, H., Li, J. J., Walker, S. J., Hong, Z., O’Connor, S. P., Nayeem, A., Camac, D. M., Morin, P. E., et al. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml500144h · Cited by 25
Calcium-Deficiency during Pregnancy Affects Insulin Resistance in Offspring
Takaya, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137008 · Cited by 25
“Experimental studies have shown higher 11β-HSD1 expression in adipose tissue associated with features of metabolic syndrome such as increased waist circumference and insulin resistance [64].”
BackgroundRecent Advances in Synthesis and Medicinal Evaluation of 1,2‐Benzothiazine Analogues
Reetu, R., Gujjarappa, R., & Malakar, C. C. (2022) · Asian Journal of Organic Chemistry · doi:10.1002/ajoc.202200163 · Cited by 25
Kim, S. H., Bok, J. H., Lee, J. H., Kim, I. H., Kwon, S. W., Lee, G. B., Kang, S. K., Park, J. S., Jung, W. H., Kim, H. Y., et al. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml200226x · Cited by 25
Serr, J., Suh, Y., Oh, S., Shin, S., Kim, M., LATSHAW, J. D., & Lee, K. (2011) · Lipids · doi:10.1007/s11745-011-3583-8 · Cited by 25
“Glucocorticoids regulate adipose differentiation, function, and distribution and in excess, promote hyperlipidemia [5].”
BackgroundSukhija, R., Kakar, P., Mehta, V., & Mehta, J. L. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.03.028 · Cited by 25
McCormick, D. L., Johnson, W. D., Kozub, N. M., Rao, K. V. N., Lubet, R. A., Steele, V. E., & Bosland, M. C. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl141 · Cited by 25
Sleep Endocrine Effects of the 11-β-Hydroxysteroiddehydrogenase Inhibitor Metyrapone
Jahn, H., Kiefer, F., Schick, M., Yassouridis, A., Steiger, A., Kellner, M. B., & Wiedemann, K. (2003) · SLEEP · doi:10.1093/sleep/26.7.823 · Cited by 25
The metabolic syndrome as a vicious cycle: does obesity beget obesity?
Girod, J. P., & Brotman, D. J. (2003) · Medical Hypotheses · doi:10.1016/s0306-9877(03)00053-7 · Cited by 25
Nobel, S., Dunås, F., & Abrahmsén, L. (2002) · Protein Expression and Purification · doi:10.1016/s1046-5928(02)00547-8 · Cited by 25
Tanaka, T., Masuzaki, H., Ebihara, K., Ogawa, Y., Yasue, S., Yukioka, H., Chusho, H., Miyanaga, F., Miyazawa, T., Fujimoto, M., et al. (2005) · Metabolism · doi:10.1016/j.metabol.2005.05.015 · Cited by 25
Self-citation11β-HSD1 reduces metabolic efficacy and adiponectin synthesis in hypertrophic adipocytes
Koh, E. H., Kim, A., Kim, H., Kim, J. H., Park, H., Ko, M. S., Kim, M., Kim, H.-J., Kim, B. J., Yoo, H. J., et al. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0117 · Cited by 24
“Adipose-specific overexpression of 11b-HSD1 in transgenic mice produced typical features of metabolic syndrome (Masuzaki et al. 2001).”
BackgroundNovel targets for the treatment of obesity: a review of progress
Cheetham, S. C., Jackson, H. C., Vickers, S. P., Dickinson, K., Jones, R. B., & Heal, D. J. (2004) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2004.09.009 · Cited by 24
Yu, J., Yu, B., He, J., Zheng, P., Mao, X., Han, G., & Chen, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112628 · Cited by 24
“In addition, mice selectively expressing the glucocorticoid-activating enzyme, 11 b-hydroxysteroid dehydrogenase type 1 (11bHSD1), in adipose tissue shows central obesity phenotype [10], whereas the suppression of 11bHSD1 attenuates adipogenesis [11].”
BackgroundOkazaki, S., Takahashi, T., Iwamura, T., Nakaki, J., Sekiya, Y., Yagi, M., Kumagai, H., Sato, M., Sakami, S., Nitta, A., et al. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.216556 · Cited by 24
“In contrast, overexpression of 11b-HSD1 in adipose tissue is associated with increased food intake (Masuzaki et al., 2001).”
BackgroundPathophysiology of Obesity—Induced Hypertension and Target Organ Damage
Hall, J. E., da Silva, A. A., Brandon, E. L., Stec, D. E., Ying, Z., & Jones, D. W. (2007) · Elsevier eBooks · doi:10.1016/b978-0-323-03961-1.50041-6 · Cited by 24
Mifepristone Improves Adipose Tissue Insulin Sensitivity in Insulin Resistant Individuals
Gubbi, S., Muniyappa, R., Sharma, S. T., Grewal, S., McGlotten, R., & Nieman, L. K. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab046 · Cited by 24
Gurnell, M. (2007) · PPAR Research · doi:10.1155/2007/83593 · Cited by 24
“In keeping with this, adipose-specific overexpression of 11β-HSD1 in transgenic mice induced a phenotype of insulin resistance and central obesity [85].”
BackgroundFundamento molecular de la esteatosis hepática asociada a la obesidad
Buqué, X., Aspichueta, P., & Ochoa, B. (2008) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082008000900007 · Cited by 24
“Habida cuenta de la elevada producción de TNF-α en individuos obesos y que el tejido adiposo visceral tiene una producción de TNF-α mayor que el tejido adiposo subdérmico (12), cabe esperar mayor resistencia a la insulina y hepatoesteatosis en individuos con obesidad troncal (83).”
BackgroundNagasawa, K., Matsuura, N., Takeshita, Y., Ito, S., Sano, Y., Yamada, Y., Uchinaka, A., Murohara, T., & Nagata, K. (2016) · Nutrition and Diabetes · doi:10.1038/nutd.2016.14 · Cited by 24
Larner, D. P., Morgan, S., Gathercole, L., Doig, C. L., Guest, P., Weston, C. J., Hazeldine, J., Tomlinson, J., Stewart, P. M., & Lavery, G. G. (2016) · Endocrinology · doi:10.1210/en.2016-1357 · Cited by 24
“Furthermore, mice with transgenic overexpression of 11 HSD1, specifically in adipose and liver, develop hepatosteatosis in the context of a high-fat diet (17, 18).”
BackgroundInfluentialImpact of MR on mature adipocytes in high-fat/high-sucrose diet-induced obesity
Hayakawa, T., Minemura, T., Onodera, T., Shin, J., Okuno, Y., Fukuhara, A., Otsuki, M., & Shimomura, I. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0026 · Cited by 25
11β-Hydroxysteroid dehydrogenase type 1 inhibitors with oleanan and ursan scaffolds
Blum, A., Favia, A. D., & Maser, E. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.08.028 · Cited by 24
“On the other hand, transgenic over-expression of 11β-HSD1 in mice adipose tissues causes visceral obesity, insulin resistance, diabetes, dyslipidemia and hypertension (Masuzaki et al., 2001; Masuzaki et al., 2003).”
Discovery of potent and selective inhibitors of 11β-HSD1 for the treatment of metabolic syndrome
Richards, S. J., Sorensen, B. K., Jae, H.-S., Winn, M., Chen, Y., Wang, J., Fung, S., Monzon, K., Frevert, E. U., Jacobson, P. B., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.09.035 · Cited by 24
Kurniati, H., Djuwita, R., & Istiqfani, M. (2023) · Jurnal Epidemiologi Kesehatan Indonesia · doi:10.7454/epidkes.v6i2.6349 · Cited by 23
Transcriptional repression of beige fat innervation via a YAP/TAZ-S100B axis
Huang, X., Li, X., Shen, H., Zhao, Y., Zhou, Z., Wang, Y., Yao, J., Xue, K., Wu, D., & Qiu, Y. (2023) · Nature Communications · doi:10.1038/s41467-023-43021-8 · Cited by 23
Hydrohysteroid Dehydrogenases – Biological Role and Clinical Importance – Review
Atanassova, N. N., & Koev, Y. (2012) · InTech eBooks · doi:10.5772/54149 · Cited by 23
“activity in adipose tissue enhances local glucocorticoid levels and produces a metabolic syndrome [196], whereas the decreased enzyme activity protects against obesity and the metabolic syndrome [200, 201].”
Drolet, B., Simard, C., & Poirier, P. (2007) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200707040-00005 · Cited by 23
Rats with Low Brain Angiotensinogen Do Not Exhibit Insulin Resistance During Early Aging
Kasper, S. O., Ferrario, C. M., Ganten, D., & Diz, D. I. (2006) · Endocrine · doi:10.1385/endo:30:2:167 · Cited by 23
Is metabolic syndrome a mild form of Cushing’s syndrome?
Krikorian, A., & Khan, M. (2010) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-010-9142-4 · Cited by 23
“Transgenic mice studies have shown that over expression of this enzyme leads to obesity, glucose intolerance and dyslipidemia [ 27 ].”
BackgroundKnüppel, S., Rohde, K., Meidtner, K., Drogan, D., Holzhütter, H., Boeing, H., & Fisher, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068941 · Cited by 23
“Haplotype analysis was done for the six genes which comprised two or more SNPs (LEPR, HSD11B1, TBC1D1, FABP2, ABCC8, and MC4R).”
BackgroundInfluentialLiu, P., Hornbuckle, L. M., Panton, L. B., Kim, J., & Ilich, J. Z. (2012) · Journal of the American College of Nutrition · doi:10.1080/07315724.2012.10720018 · Cited by 23
“myocardial infarction, and all-cause mortality [1–6].”
Sakamuri, S. S. V. P., Anamthathmakula, P., Kumar, C. P., Reddy, S. J., Giridharan, N. V., & Vajreswari, A. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-132 · Cited by 23
“Transgenic mice overexpressing 11b-HSD1 in adipose tissue have developed visceral obesity with increased preadipocyte differentiation [7].”
BackgroundChen, X., Shao, L., Pal, M., Shen, Y., Cheng, X. D., Xu, G., Peng, L., Wang, K., Pan, Z., Li, M., et al. (2015) · Journal of Natural Products · doi:10.1021/np500896n · Cited by 23
Abulizi, A., Camporez, J. P., Jurczak, M. J., Høyer, K. F., Zhang, D., Cline, G. W., Samuel, V. T., Shulman, G. I., & Vatner, D. F. (2019) · The FASEB Journal · doi:10.1096/fj.201802706r · Cited by 23
Miyamoto, Y., Morisaki, H., Yamanaka, I., Kokubo, Y., Masuzaki, H., Okayama, A., Tomoike, H., Nakao, K., Okamura, T., Yoshimasa, Y., et al. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.05.017 · Cited by 23
Self-citationRyu, J. H., Lee, J. A., Kim, S., Shin, Y. A., Yang, J., Han, H. Y., Son, H. J., Kim, Y. H., Sa, J. H., Kim, J.-S., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01122 · Cited by 23
Paulsen, S. K., Nielsen, M. P., Richelsen, B., Bruun, J. M., Flyvbjerg, A., & Pedersen, S. B. (2008) · Obesity · doi:10.1038/oby.2008.2 · Cited by 23
“Studies of transgenic mice have shown that increased adipose 11β-HSD1 expression is associated with the development of the metabolic syndrome (20,21), and conversely that improved inactivation of glucocorticoid in adipocytes protects against metabolic syndrome (22).”
BackgroundMlinar, B., Marc, J., Jensterle, M., Bokal, E. V., Jerin, A., & Pfeifer, M. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.12.002 · Cited by 23
Liu, W., Liu, M., Fan, W., Nawata, H., & Yanase, T. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.02.007 · Cited by 23
Early onset adiposity: a pathway to polycystic ovary syndrome in adolescents?
Diamanti‐Kandarakis, E., Christakou, C. D., Kandaraki, E., & Alexandraki, K. (2007) · PubMed · Cited by 23
Putignano, P., Giraldi, F. P., & Cavagnini, F. (2004) · Journal of Endocrinological Investigation · doi:10.1007/bf03347544 · Cited by 23
Glucocorticoid Resistance and Hypersensitivity
Malchoff, C. D., & Malchoff, D. M. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.02.002 · Cited by 23
“Transgenic mice that overexpress 11b-HSD1 in adipose tissue develop the metabolic syndrome [42].”
BackgroundKristan, K., Rižner, T. L., Stojan, J., Gerber, J., Kremmer, E., & Adamski, J. (2003) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00205-3 · Cited by 23
Regulation of lipid droplet dynamics and lipid homeostasis by hydroxysteroid dehydrogenase proteins
Liang, B., Fu, L., & Liu, P. (2024) · Trends in Cell Biology · doi:10.1016/j.tcb.2024.10.010 · Cited by 23
Lipid Hormones at the Intersection of Metabolic Imbalances and Endocrine Disorders
Dobre, M.-Z., Vîrgolici, B., & Cioarca-Nedelcu, R. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47070565 · Cited by 23
“Transgenic mice with the selective overexpression of 11 β -hydroxysteroid dehydrogenase type 1 (11 β -HSD1) in adipose tissue develop pronounced visceral obesity, which is further exacerbated by a high-fat diet, along with insulin resistance and diabetes [30].”
A gene variant of 11β-hydroxysteroid dehydrogenase type 1 is associated with obesity in children
Olza, J., Gil‐Campos, M., Leis, R., Rupérez, A. I., Tojo, R., Cañete, R., Gil, Á., & Aguilera, C. M. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.4 · Cited by 22
Methlie, P., Dankel, S. N., Myhra, T. S., Christensen, B. J., Gjerde, J., Fadnes, D. J., Våge, V., Løvås, K., & Mellgren, G. (2013) · Obesity · doi:10.1002/oby.20449 · Cited by 22
“Evidence derived from transgenic mice selectively overexpressing HSD11B1 in adipose tissues indicates that increased active glucocorticoid hormone in fat produces visceral obesity, insulin resistance, and features of the metabolic syndrome (11).”
BackgroundRoche, D., Carniato, D., Leriche, C., Lepifre, F., Christmann‐Franck, S., Grädler, U., Charon, C., Hallakou‐Bozec, S., Doaré, L., Schmidlin, F., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.03.140 · Cited by 22
Sharma, M., Vikram, N. K., Misra, A., Bhatt, S., Tarique, M., Parray, H. A., Pandey, R. M., & Luthra, K. (2013) · Molecular Biology Reports · doi:10.1007/s11033-013-2738-5 · Cited by 22
“Transgenic mice overexpressing 11-bHSD1 in adipose tissue developed visceral obesity, insulin resistant state and hyperlipidemia, suggesting its role in abdominal obesity and metabolic syndrome [7].”
BackgroundYe, X., Chen, S., Wu, S. C., Yoon, D. S., Wang, H., Hong, Z., O’Connor, S. P., Li, J., Li, J. J., Kennedy, L. J., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00211 · Cited by 22
Nday, C. M., Eleftheriadou, D., & Jackson, G. E. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14256 · Cited by 22
“Finally, aberrations in circulating glucocorticoid (GC) levels have been stated as an alternative molecular etiology for obesity’s neurocognitive defects (Masuzaki et al., 2001).”
BackgroundInfluentialTomasson, M. H., Ali, M., Oliveira, V. D., Xiao, Q., Jethava, Y. S., Zhan, F., Fitzsimmons, A. M., & Bates, M. L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113621 · Cited by 22
Abulizi, A., Camporez, J. P., Zhang, D., Samuel, V. T., Shulman, G. I., & Vatner, D. F. (2018) · Metabolism · doi:10.1016/j.metabol.2018.12.003 · Cited by 22
“Specifically, increased adipose 11βhydroxysteroid dehydrogenase type 1 (HSD11B1) activity, which regenerates active cortisol from inactive metabolites, has been associated with obesity and insulin resistance in humans [1, 2] with obesity and insulin resistance; furthermore, a mouse model with adipose specific overexpr…”
BackgroundInfluential
Metadata
- Authors
- Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- University of Edinburgh (GB)
- Corresponding author
- Flier, Jeffrey S.
- Venue
- Science
- Published
- 2001-12-07
- Volume
- 294
- Issue
- 5549
- Pages
- 2166-2170
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2117268230
- Cited by
- 1,766
- References
- 34
- Citations by year
- 2026: 9 · 2025: 21 · 2024: 30 · 2023: 19 · 2022: 23 · 2021: 44 · 2020: 34 · 2019: 39 · 2018: 54 · 2017: 52 · 2016: 63 · 2015: 74 · 2014: 72 · 2013: 106 · 2012: 98
- FWCI
- 71.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- visceral obesity, metabolic syndrome, 11β-hydroxysteroid dehydrogenase type 1, glucocorticoids, corticosterone, adipose tissue, transgenic mice, insulin resistance, diabetes mellitus, hyperlipidemia, hyperphagia, leptin, high-fat diet
- MeSH terms
- Abdomen, Adipose Tissue, Animals, Body Composition, Corticosterone, Dietary Fats, Disease Models, Animal, Eating, Humans, Hydroxysteroid Dehydrogenases, Hyperglycemia, Hyperinsulinism, Insulin Resistance, Lipids, Lipoprotein Lipase, Male, Mice, Transgenic, Obesity, Receptors, Glucocorticoid, Viscera, Weight Gain, Adipocytes, Gene Targeting, Leptin, Metabolic Syndrome, 11-beta-Hydroxysteroid Dehydrogenase Type 1, Cell Size, Lipid Metabolism, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.